KRISTIN BOATFIELD: Open Payments
NPI 1427803055 · LEESBURG, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 51 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $380 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $238 |
| AstraZeneca Pharmaceuticals LP | 8 | $215 |
| PFIZER INC. | 6 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Atland Pharmaceuticals, LLC | 1 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Amgen Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: AIRSUPRA, VRAYLAR, NURTEC ODT, CAPLYTA, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Kerendia, QULIPTA, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
